Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation. Kassie F, Bagherpoor AJ, Kovacs K, Seelig D, et al. Carcinogenesis 2022;43:547-556.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kassie F, Bagherpoor AJ, Kovacs K, Seelig D, et al. Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation. Carcinogenesis 2022;43:547-556.
PMID: 35147705